Page last updated: 2024-10-30

leflunomide and Stevens-Johnson Syndrome

leflunomide has been researched along with Stevens-Johnson Syndrome in 4 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"Leflunomide is an immunomodulating agent with proven efficacy in rheumatoid arthritis."7.74Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis. ( Baaj, M; El Haouri, M; Hadri, L; Hassikou, H; Safi, S; Tabache, F, 2008)
"Leflunomide is an immunomodulating agent with proven efficacy in rheumatoid arthritis."3.74Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis. ( Baaj, M; El Haouri, M; Hadri, L; Hassikou, H; Safi, S; Tabache, F, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Wang, Y1
Wang, F1
Li, H1
Hao, X1
Shen, G1
Sun, Y1
Xia, J1
Hassikou, H1
El Haouri, M1
Tabache, F1
Baaj, M1
Safi, S1
Hadri, L1
Schmutz, JL1
Barbaud, A1
Tréchot, P1
Teraki, Y1
Hitomi, K1
Sato, Y1
Hamamatsu, Y1
Izaki, S1

Other Studies

4 other studies available for leflunomide and Stevens-Johnson Syndrome

ArticleYear
Toxic Epidermal Necrolysis Induced by Leflunomide in a Patient With Rheumatoid Arthritis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Dec-01, Volume: 27, Issue:8S

    Topics: Arthritis, Rheumatoid; Humans; Leflunomide; Stevens-Johnson Syndrome

2021
Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Joint bone spine, 2008, Volume: 75, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Arthritis, Rheumatoid; Cholestyramine Resin; Female; Glucocorticoids;

2008
[Leflunomide and Lyell syndrome].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:4

    Topics: Adult; Arthritis, Rheumatoid; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Isoxazoles; L

2009
Leflunomide-induced toxic epidermal necrolysis.
    International journal of dermatology, 2006, Volume: 45, Issue:11

    Topics: Adjuvants, Immunologic; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Middle Aged;

2006